Skip to main content

HARVARD BIOSCIENCE INC

For the period ended Jun 30, 2026. Filed Aug 11, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 11, 2026

HBIO$9.09+8.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

FORM 10-Q

INDEX

Page
PART I - FINANCIAL INFORMATION1
Item 1. Financial Statements (unaudited)1
Condensed Consolidated Balance Sheets1
Condensed Consolidated Statements of Operations2
Condensed Consolidated Statements of Comprehensive Loss3
Condensed Consolidated Statements of Stockholders' Equity4
Condensed Consolidated Statements of Cash Flows5
Notes to Condensed Unaudited Consolidated Financial Statements6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3. Quantitative and Qualitative Disclosures about Market Risk23
Item 4. Controls and Procedures24
PART II - OTHER INFORMATION24
Item 1. Legal Proceedings24
Item1A. Risk Factors24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.24
Item 3. Defaults Upon Senior Securities24
Item 4. Mine Safety Disclosures24
Item 5. Other Information24
Item 6. Exhibits25
SIGNATURES25

**PART I. FINANCIAL INFORMATION

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.